Full Press Release Details
of Director's Interest Notice
of Director's Interest Notice
or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property
and may be made public.
30/09/01 Amended 01/01/11
| Name of entity | INCANNEX HEALTHCARE LIMTIED |
| ABN | 93 096 635 246 |
(the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section
205G of the Corporations Act.
| Name of Director | Peter Widdows |
| Date of last notice | 6 June 2023 |
1 - Change of director's relevant interests in securities
the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director"
should be disclosed in this part.
| Direct or indirect interest | Direct and indirect |
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | The Peter Widdows Superannuation Fund (Beneficiary) Wealthhub Securities Noms P/L <JBWERE ACCUMULATION> (Beneficiary) |
| Date of change | 31 October 2023 |
| No. and class of securities held prior to change | DIRECT 15,973,694 IHL ordinary shares 1,064,913 unlisted $0.025 options expiring on 30 April 2026 INDIRECT 600,000 IHL ordinary shares 40,000 unlisted $0.025 options expiring on 30 April 2026 |
| Number acquired | DIRECT 230,954 IHL ordinary shares INDIRECT 280,000 IHL ordinary shares |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | $33,842.10 |
| + See chapter 19 for defined terms. | |
| 01/01/2011 Appendix 3Y Page 1 |
of Director's Interest Notice
| No. of securities held after change | DIRECT 16,204,648 IHL ordinary shares 1,064,913 unlisted $0.025 options expiring on 30 April 2026 INDIRECT 880,000 IHL ordinary shares 40,000 unlisted $0.025 options expiring on 30 April 2026 |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | On Market Purchase |
2 - Change of director's interests in contracts
In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director"
should be disclosed in this part.
| Detail of contract | N/A |
| Nature of interest | |
| Name of registered holder (if issued securities) | |
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
| Interest after change |
| Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? | No. |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | |
| If prior written clearance was provided, on what date was this provided? |
| + See chapter 19 for defined terms. | |
| Appendix 3Y Page 2 | 01/01/2011 |
Director's Interest Notice
Change of Director's Interest Notice
Information or documents not
available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be
30/09/01 Amended 01/01/11
| Name of entity | INCANNEX HEALTHCARE LIMTIED |
| ABN | 93 096 635 246 |
We (the entity) give ASX the
following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Troy Valentine |
| Date of last notice | 6 June 2023 |
of director's relevant interests in securities
In the case of a trust, this
includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company,
interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in
| Direct or indirect interest | Direct and indirect |
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | See notes below |
| Date of change | 3 November 2023 |
| No. and class of securities held prior to change | 36, 651 198 IHL Ordinary Shares 2,800,000 Options with various exercise prices, vesting dates and expiry dates. 2,443,413 unlisted $0.025 options expiring on 30 April 2026 |
| Number acquired | 11,091,950 IHL Ordinary Shares |
| Number disposed | 11,091,950 IHL Ordinary Shares |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | $887,356 |
| No. of securities held after change | 36, 651 198 IHL Ordinary Shares 2,800,000 Options with various exercise prices, vesting dates and expiry dates. 2,443,413 unlisted $0.025 options expiring on 30 April 2026 |
| + See chapter 19 for defined terms. | |
| 01/01/2011 Appendix 3Y Page 1 |
Director's Interest Notice
Change of director's interests in contracts
Note: In the case of a company,
interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in
| Detail of contract | N/A |
| Nature of interest | |
| Name of registered holder (if issued securities) | |
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | |
| Interest after change |
| Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? | No. |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | |
| If prior written clearance was provided, on what date was this provided? |
| + See chapter 19 for defined terms. | |
| Appendix 3Y Page 2 | 01/01/2011 |
Change of Director's
Direct & Indirect Interests
(a) Description of entities/relationships:
(b) Table 1 - holdings
| IHL Ordinary Shares | IHL Options | |
| Troy Valentine | 2,925,000^ | 2,800,000^^ |
| Ekirtson * | 2,875,000 | |
| Tranaj * | 10,216,950 | |
| Valplan | 3,000,000 | |
| Alignment * | 13,194,248 | |
| Cityside | 4,440,000 | |
| TOTAL | 36,651,198 |
(c) Table 2 - holdings
| IHL Ordinary Shares | IHL Options | |
| Troy Valentine | 2,925,000^ | 2,994,999^^ |
| Ekirtson * | 1,000,000 | 191,667 |
| Tranaj * | 1,000,000 | 681,130 |
| Valplan | 3,000,000 | 200,000 |
| Alignment * | 24,286,198 | 879,617 |
| Cityside | 4,440,000 | 296,000 |
| TOTAL | 36,651,198 |
| + See chapter 19 for defined terms. | |
| 01/01/2011 Appendix 3Y Page 3 |